Abstract:BackgroundFactitious hypoglycemia, a deliberate attempt to induce low blood glucose levels occurring secondary to the surreptitious administration of exogenous insulin, can be difficult to diagnose due to a variety of factors including the increased use of synthetic insulin analogs in clinical practice. Traditional insulin immunoassays demonstrate variable cross-reactivity with commonly prescribed insulin analogues and their metabolites, making it difficult to measure specific analogs. The development of liquid chromatography high resolution accurate mass (LC-HRAM)-mass spectrometry (MS) assays has largely circumvented the limitations of traditional immunoassays for detection and quantitation of insulin analogs. Analytical challenges remain, however, specifically in differentiating lispro, an isomeric human insulin analog formed by the transposition of proline and lysine near the C-terminal end of the B chain, from human insulin in patient samples due to the equivalent mass-to-charge ratios of their precursor ions.MethodsImmunoaffinity purification of insulin from calibrators and quality control material prepared by spiking insulin-depleted serum with pharmaceutical insulin preparations, as well as patient samples, was performed using tips coupled with anti-insulin monoclonal antibody. An automated liquid handler was programmed to perform aspiration and dispense cycles. Eluate from the purification protocol was submitted for analysis using a TLX-2 multiplex LC system paired with a Thermo Scientific Q Exactive Plus mass spectrometer. Various HPLC column chemistries were evaluated, a column passivation procedure was established, and column heater temperature was optimized to identify a combination of parameters yielding the best chromatographic separation of human insulin and lispro. Additionally, parallel reaction monitoring (PRM) targeted tandem mass spectrometry (MS/MS) analysis was utilized in combination with the full scan data to increase specificity through the monitoring of fragment ions produced from human insulin and each insulin analog.ResultsWe found that a 1000 Å Diphenyl, 2.7 μm, 2.1 x 100 mm analytical column in a column heater maintained at a temperature of 80°C allowed for human insulin and lispro to be differentiated as two chromatographically separated extracted ion chromatographic peaks (XICs) and quantified down to 2.5 mcIU/mL with near-baseline separation. Before use, the column required passivation with a high protein buffer (0.05% bovine serum albumin in 20% acetonitrile [ACN] + 0.2% acetic acid) followed by increasingly organic buffers (20% ACN + 0.2% acetic acid and 50% ACN + 0.2% acetic acid). MS/MS was used to confirm the presence of analogs detected.ConclusionsThe LC-HRAM-MS method described here, coupled with optimized column chemistry, column passivation, and proper column temperature control allows for chromatographic separation of human insulin and lispro. Incorporating a PRM scan into the mass spectrometry full scan method provides confirmation of the insulin detected in the XICs. The results obtained from preliminary studies suggest this method is appropriate for use to facilitate the clinical investigation of suspected factitious hypoglycemia with the ability to differentiate isomeric compounds, such as human insulin and lispro.

Application of electrospray ionization-mass spectrometry to screen extractants for determination of insulin in an emulsion system by HPLC-UV

Ultrasound-Assisted Extraction of Soyasaponins from Hypocotyls, and Analysis by LC-ESI-MS

Rapid Quantitative Determination and Assessment of Insulin in Oil Formulation by Micellar Electrokinetic Capillary Chromatography

Quantification of Soybean Phospholipids in Soybean Degummed Oil Residue by Hplc with Evaporative Light Scattering Detection

Study on Pre- Treatment Methods & RP- HPLC Determination of Insulin in Self- Micro- Emulsifying Oily Formulations

Quantitative Determination of Insulin Entrapment Efficiency in Triblock Copolymeric Nanoparticles by High-Performance Liquid Chromatography.

Soybean lecithin acts as both absorption enhancer and oily phase in an insulin-loaded emulsion system for transmucosal delivery

[Simultaneous Determination of Six Components in Water Extract and Alcohol Precipitation Liquid in Astragali Radix by HPLC-UV-ELSD].

High-throughput semi-automated emulsive liquid-liquid microextraction for detecting SDHI fungicides in water, juice, and alcoholic beverage samples via UHPLC-MS/MS

Optimized LC-MS/MS method for quantifying insulin degludec and liraglutide in rat plasma and Tissues: Application in pharmacokinetics and biodistribution

Simplified quantification of insulin, its synthetic analogs and C-peptide in human plasma by means of LC-HRMS

Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography-high resolution mass spectrometry

Determination of Insulin in Aerosol by High-Performance Capillary Electrophoresis

Detection of recombinant insulins in human urine by liquid chromatography–electrospray ionization tandem mass spectrometry after immunoaffinity purification based on monolithic microcolumns

Analysis of Insulin by High Performance Liquid Chromatographic Method with Precolumn Derivatization with 4‐Chloro‐7‐nitrobenzo‐2‐oxa‐1,3‐diazole

Development and Application of Capillary Electrophoresis-Electrospray Ionization Mass Spectrometry System Based on A Coaxial Sheath Flow Interface

C18-attached Membrane Funnel-Based Spray Ionization Mass Spectrometry for Quantification of Anti-Diabetic Drug from Human Plasma.

Ionic liquid-based dispersive liquid-liquid microextraction followed by dispersive solid phase extraction coupled with HPLC-DAD for the determination of sulfonylurea herbicides in soymilk samples

Utilizing ELISA-plate based immunopurification and liquid chromatography-tandem mass spectrometry for the urinary detection of short- and long acting human insulin analogues

Direct Coupling of Thin-Layer Chromatography-Bioautography with Electrostatic Field Induced Spray Ionization-Mass Spectrometry for Separation and Identification of Lipase Inhibitors in Lotus Leaves.

B-150 Chromatographic Separation and Quantitation of Human Insulin and Lispro Analog in Serum Using Liquid Chromatography High-Resolution Mass Spectrometry